1. Home
  2. CRNX vs PCH Comparison

CRNX vs PCH Comparison

Compare CRNX & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • PCH
  • Stock Information
  • Founded
  • CRNX 2008
  • PCH 1903
  • Country
  • CRNX United States
  • PCH United States
  • Employees
  • CRNX N/A
  • PCH N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • PCH Real Estate Investment Trusts
  • Sector
  • CRNX Health Care
  • PCH Real Estate
  • Exchange
  • CRNX Nasdaq
  • PCH Nasdaq
  • Market Cap
  • CRNX 2.8B
  • PCH 3.3B
  • IPO Year
  • CRNX 2018
  • PCH N/A
  • Fundamental
  • Price
  • CRNX $33.77
  • PCH $40.51
  • Analyst Decision
  • CRNX Strong Buy
  • PCH Strong Buy
  • Analyst Count
  • CRNX 7
  • PCH 6
  • Target Price
  • CRNX $74.33
  • PCH $49.67
  • AVG Volume (30 Days)
  • CRNX 1.1M
  • PCH 446.7K
  • Earning Date
  • CRNX 11-11-2025
  • PCH 10-27-2025
  • Dividend Yield
  • CRNX N/A
  • PCH 4.43%
  • EPS Growth
  • CRNX N/A
  • PCH 15.06
  • EPS
  • CRNX N/A
  • PCH 0.53
  • Revenue
  • CRNX $1,392,000.00
  • PCH $1,056,523,000.00
  • Revenue This Year
  • CRNX $489.51
  • PCH $4.42
  • Revenue Next Year
  • CRNX $661.93
  • PCH $3.61
  • P/E Ratio
  • CRNX N/A
  • PCH $76.72
  • Revenue Growth
  • CRNX 0.51
  • PCH N/A
  • 52 Week Low
  • CRNX $24.10
  • PCH $36.82
  • 52 Week High
  • CRNX $62.53
  • PCH $48.12
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 56.44
  • PCH 42.44
  • Support Level
  • CRNX $33.19
  • PCH $41.22
  • Resistance Level
  • CRNX $37.23
  • PCH $42.79
  • Average True Range (ATR)
  • CRNX 1.45
  • PCH 1.03
  • MACD
  • CRNX 0.11
  • PCH -0.18
  • Stochastic Oscillator
  • CRNX 52.12
  • PCH 3.43

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

Share on Social Networks: